13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001920938
Total reported value
$2.7B
$2.7B
73 檔
27.6%
In Q4 2024, Braidwell LP's U.S. equity holdings reached a combined market value of $2.7B, distributed across 73 disclosed stock positions.
Braidwell LP executed strategic sector rebalancing during Q4 2024, establishing 14 new positions while fully exiting 22 holdings and trimming 17 positions.
In terms of portfolio concentration, the top 5 core holdings (including GH 0 11-15-27, BBIO 2.5 03-15-27, NVCR 0 11-01-25) accounted for 27.6% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GH 0 11-15-27Bond | Guardant Health Inc | Bond | 6.70% | — | — | |
| 2 | BBIO 2.5 03-15-27Bond | Bridgebio Pharma Inc | Bond | 4.39% | — | — | |
| 3 | NVCR 0 11-01-25Bond | Novocure LTD | Bond | 3.99% | — | — | |
| 4 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 3.65% | -0.77% | -1.73% | |
| 5 | RGEN 1 12-15-28Bond | Repligen CORP | Bond | 3.40% | -2.68% | — | |
| 6 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 3.39% | -0.07% | +7.64% | |
| 7 | GMED 0.375 03-15-25Bond | Nuvasive Inc | Bond | 3.36% | — | — | |
| 8 | NEO 0.25 01-15-28Bond | Neogenomics Inc | Bond | 2.91% | -2.44% | — | |
| 9 | LEGN | Legend Biotech Corp-adr | Stock-Other | 2.87% | — | +93.18% | |
| 10 | CGON | Cg Oncology Inc | Stock-Other | 2.79% | -2.22% | EXIT | |
| 11 | GH | Guardant Health Inc | Stock-Healthcare | 2.58% | -0.72% | -14.79% | |
| 12 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | Bond | 2.53% | — | — | |
| 13 | ALGN | Align Technology Inc | Stock-Healthcare | 2.32% | — | +20.37% | |
| 14 | DXCM 0.375 05-15-28Bond | Dexcom Inc | Bond | 2.21% | — | -10.79% | |
| 15 | APGE | Apogee Therapeutics Inc | Stock-Other | 2.07% | -1.34% | EXIT | |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | Stock-Other | 2.02% | -0.01% | +19.28% | |
| 17 | APLSUSD | Apellis Pharmaceuticals Inc | Stock-Other | 1.99% | — | -32.84% | |
| 18 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 1.89% | +0.48% | -9.86% | |
| 19 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.85% | +0.53% | +19.09% | |
| 20 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 1.83% | — | — | |
| 21 | SYRE | Spyre Therapeutics Inc | Stock-Other | 1.78% | +1.32% | +17.74% | |
| 22 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 1.77% | — | +27.89% | |
| 23 | TMDX | Transmedics Group Inc | Stock-Healthcare | 1.70% | +0.41% | — | |
| 24 | ATEC 0.75 08-01-26Bond | Alphatec Holdings Inc | Bond | 1.63% | — | — | |
| 25 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.61% | -0.05% | +22.81% | |
| 26 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.47% | -1.46% | -16.50% | |
| 27 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 1.38% | +0.14% | — | |
| 28 | BBIO 2.25 02-01-29Bond | Bridgebio Pharma Inc | Bond | 1.36% | — | — | |
| 29 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 1.35% | +1.04% | — | |
| 30 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.32% | — | -1.48% | |
| 31 | PEN | Penumbra Inc | Stock-Healthcare | 1.29% | -1.15% | EXIT | |
| 32 | GKOS | Glaukos CORP | Stock-Healthcare | 1.28% | +0.32% | -7.30% | |
| 33 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 1.28% | — | +21.15% | |
| 34 | RGEN | Repligen CORP | Stock-Healthcare | 1.21% | +0.70% | -28.47% | |
| 35 | FNAUSD | Paragon 28 Inc | Stock-Other | 1.17% | — | -7.26% | |
| 36 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.17% | -0.16% | -17.52% | |
| 37 | ATEC | Alphatec Holdings Inc | Stock-Other | 1.16% | +1.30% | +5.33% | |
| 38 | BNTX | Biontech Se-adr | Stock-Other | 1.05% | — | +25.07% | |
| 39 | BCAX | Bicara Therapeutics Inc | Stock-Other | 1.03% | — | +20.70% | |
| 40 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.93% | +0.20% | +18.86% | |
| 41 | HROW | Harrow Inc | Stock-Other | 0.90% | -0.18% | EXIT | |
| 42 | KROS | Keros Therapeutics Inc | Stock-Other | 0.89% | — | +167.86% | |
| 43 | ORKA | Oruka Therapeutics Inc | Stock-Other | 0.80% | +0.98% | NEW | |
| 44 | DNTH | Dianthus Therapeutics Inc | Stock-Other | 0.78% | -0.38% | +144.40% | |
| 45 | KIDS | Orthopediatrics CORP | Stock-Other | 0.76% | +0.20% | — | |
| 46 | ✓ | Immatics NV | Stock-Other | 0.74% | — | +112.68% | |
| 47 | GERN | Geron CORP | Stock-Other | 0.74% | — | — | |
| 48 | IRWD | Ironwood Pharmaceuticals Inc | Stock-Other | 0.71% | — | +22.58% | |
| 49 | BRKR | Bruker CORP | Stock-Healthcare | 0.61% | — | — | |
| 50 | EXK | Exact Sciences CORP | Stock-Materials | 0.59% | — | +23.35% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RGEN 1 12-15-28Bond | Repligen CORP | +3.4% | NEW | New buy |
| 2 | TMDX | Transmedics Group Inc | +1.7% | NEW | New buy |
| 3 | TMO | Thermo Fisher Scientific Inc | +1.4% | NEW | New buy |
| 4 | GERN | Geron CORP | +0.7% | NEW | New buy |
| 5 | LEGN | Legend Biotech Corp-adr | +0.7% | +93.18% | Add |
| 6 | NBIX | Neurocrine Biosciences Inc | +0.7% | -1.73% | Trim |
| 7 | BRKR | Bruker CORP | +0.6% | NEW | New buy |
| 8 | GH 0 11-15-27Bond | Guardant Health Inc | +0.6% | — | Unchanged |
| 9 | NUVL | Nuvalent Inc-a | +0.6% | NEW | New buy |
| 10 | ATEC | Alphatec Holdings Inc | +0.5% | +5.33% | Add |
| 11 | DYN | Dyne Therapeutics Inc | +0.5% | NEW | New buy |
| 12 | ORKA | Oruka Therapeutics Inc | +0.4% | +122.54% | Add |
| 13 | CADL | Candel Therapeutics Inc | +0.4% | NEW | New buy |
| 14 | GH | Guardant Health Inc | +0.4% | -14.79% | Trim |
| 15 | DNTH | Dianthus Therapeutics Inc | +0.4% | +144.40% | Add |
| 16 | FNAUSD | Paragon 28 Inc | +0.4% | -7.26% | Trim |
| 17 | EWTX | Edgewise Therapeutics Inc | +0.4% | +19.09% | Add |
| 18 | XENE | Xenon Pharmaceuticals Inc | +0.4% | +7.64% | Add |
| 19 | RCUS | Arcus Biosciences Inc | +0.4% | NEW | New buy |
| 20 | HROW | Harrow Inc | +0.3% | +106.31% | Add |
| 21 | BBIO 2.5 03-15-27Bond | Bridgebio Pharma Inc | +0.3% | — | Unchanged |
| 22 | IRTC | Irhythm Holdings Inc | +0.2% | -9.86% | Trim |
| 23 | BNTX | Biontech Se-adr | +0.2% | +25.07% | Add |
| 24 | ✓ | Immatics NV | +0.2% | +112.68% | Add |
| 25 | NVCR 0 11-01-25Bond | Novocure LTD | +0.2% | — | Unchanged |
| 26 | JSPR | Jasper Therapeutics Inc | +0.2% | +47.87% | Add |
| 27 | IRWD | Ironwood Pharmaceuticals Inc | +0.2% | +22.58% | Add |
| 28 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | +0.2% | — | Unchanged |
| 29 | GMED 0.375 03-15-25Bond | Nuvasive Inc | +0.2% | — | Unchanged |
| 30 | INSP | Inspire Medical Systems Inc | +0.2% | +22.81% | Add |
| 31 | CBLL | Ceribell Inc | +0.2% | NEW | New buy |
| 32 | NEO 0.25 01-15-28Bond | Neogenomics Inc | +0.2% | — | Unchanged |
| 33 | XNCR | Xencor Inc | +0.2% | +31.96% | Add |
| 34 | ATEC 0.75 08-01-26Bond | Alphatec Holdings Inc | +0.1% | — | Unchanged |
| 35 | GKOS | Glaukos CORP | +0.1% | -7.30% | Trim |
| 36 | ✓ | +0.1% | NEW | New buy | |
| 37 | BBIO 2.25 02-01-29Bond | Bridgebio Pharma Inc | +0.1% | — | Unchanged |
| 38 | SKYE | Skye Bioscience Inc | +0.1% | NEW | New buy |
| 39 | ALGN | Align Technology Inc | +0.1% | +20.37% | Add |
| 40 | KRYS | Krystal Biotech Inc | +0.1% | +18.86% | Add |
| 41 | EXK | Exact Sciences CORP | 0% | +23.35% | Add |
| 42 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +21.15% | Add |
| 43 | PTGX | Protagonist Therapeutics Inc | 0% | NEW | New buy |
| 44 | VRDN | Viridian Therapeutics Inc | 0% | NEW | New buy |
| 45 | SRPT | Sarepta Therapeutics Inc | 0% | -1.48% | Trim |
| 46 | ✓ | Elevation Oncology Inc | 0% | EXIT | Sold out |
| 47 | ARGX | Argenx Se - Adr | 0% | -16.50% | Trim |
| 48 | KNSA | Kiniksa Pharmaceuticals International, plc | 0% | +19.28% | Add |
| 49 | CELC | Celcuity Inc | 0% | — | Unchanged |
| 50 | ✓ | Dbv Technologies S A | 0% | EXIT | Sold out |
According to official SEC Form 13F filings, Braidwell LP reported a total U.S. public equity portfolio value of $2.7B across 73 disclosed positions in Q4 2024.
During Q4 2024, Braidwell LP's top holdings by market value included GH 0 11-15-27 (6.7%)、BBIO 2.5 03-15-27 (4.4%)、NVCR 0 11-01-25 (4.0%). The largest single position, GH 0 11-15-27, represented 6.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
RGEN 1 12-15-28
市值: $114.8M
Top Position Liquidated / Trimmed
PODD 0.375 09-01-26
前期市值: $76.4M
In Q4 2024, Braidwell LP made 76 total portfolio adjustments, initiating 14 new buys, adding to 23 positions, trimming 17 holdings, and fully liquidating 22 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.